-+ 0.00%
-+ 0.00%
-+ 0.00%
Pharvaris Presents Phase 3 Deucrictibant Data at ACAAI Annual Scientific Meeting
Share
Listen to the news
Pharvaris Presents Phase 3 Deucrictibant Data at ACAAI Annual Scientific Meeting
  • Pharvaris will present at the ACAAI Annual Scientific Meeting in Phoenix, Arizona, November 12-16, 2026.
  • A late-breaking oral presentation on November 14 will feature Phase 3 CHAPTER-3 data on extended-release deucrictibant for hereditary angioedema attack prevention.
  • Five poster presentations scheduled November 13-15 will cover additional clinical and real-world data.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharvaris NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610290650PRIMZONEFULLFEED9855627) on October 29, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending